Find A Portfolio/Ticker
Comparison Box
MyPlanIQ
Encore Dermatology 401(k) and Profit Sharing Plan
Encore Dermatology 401(k) and Profit Sharing Plan Strategic Asset Allocation - Equal Weight Moderate
Encore Dermatology 401(k) and Profit Sharing Plan Strategic Asset Allocation - Equal Weight Moderate
live (public) 0.58% February 28
Delayed
Holdings (As of 10/31/2024)
sign up and login first and then customize a new portfolio for the latest current holdings
Asset | Fund in this portfolio | Price change* | Original Fund Description | Percentage |
---|---|---|---|---|
CASH | CASH (CASH) | 0.0% | Fidelity Money Market Fund | 0.23% |
International Equity | WCMIX (WCM FOCUSED INTERNATIONAL GROWTH FUND INSTITUTIONAL CLASS) | 1.71% | WCM Focused International Growth Instl | 29.99% |
General Bond | RNSIX (RIVERNORTH/DOUBLELINE STRATEGIC INCOME FUND CLASS I) | 0.11% | RiverNorth Doubleline Strategic Inc I | 18.62% |
General Bond | OSTIX (OSTERWEIS STRATEGIC INCOME FUND INVESTOR CLASS) | 0.09% | Osterweis Strategic Income | 20.17% |
US Equity | DFUSX (U.S. LARGE COMPANY PORTFOLIO U.S. LARGE COMPANY PORTFOLIO) | 1.87% | DFA US Large Company | 15.07% |
US Equity | VDADX (VANGUARD DIVIDEND APPRECIATION INDEX FUND ADMIRAL SHARES) | 1.22% | Vanguard Dividend Appreciation Idx Adm | 15.92% |
* Day change on 10/31/2024.

Beta
Performance (As of 02/28/2025)
Since 12/31/2000
Name | YTD* Return |
1Yr AR** |
3Yr AR** |
5Yr AR** |
10Yr AR** |
15Yr AR** |
---|---|---|---|---|---|---|
Encore Dermatology 401(k) and Profit Sharing Plan Strategic Asset Allocation - Equal Weight Moderate | 6.5% | 17.6% | 4.9% | 9.1% | 6.8% | 7.0% |
VFINX (Vanguard (S&P 500) Index) | 7.9% | 15.1% | 19.4% | 16.0% | 13.5% | 14.6% |
VBINX (Vanguard Balance (60% stocks/40% bonds) | 5.6% | 10.2% | 12.1% | 8.5% | 8.3% | 9.4% |
* YTD: Year to Date
** AR: Annualized Return
** portfolio AR is delayed
Last 1 Week* | YTD*(2025) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 15 Yr | 20 Yr | 20 Yr | Since 01/02/2001 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annualized Return(%) | 0.7 | 6.5 | 17.6 | 4.9 | 9.1 | 6.8 | 7.0 | 7.4 | 6.3 | 6.6 | 6.8 | 6.1 | 10.6 | -10.2 | 11.6 | 20.9 | 22.9 | -3.6 | 8.5 | 1.9 | -2.0 | 0.5 | 15.6 | 9.4 | 2.9 | 12.3 | 21.8 | -21.7 | 9.2 | 11.0 | 7.0 | 11.2 | 21.9 | -3.1 | 8.9 |
Sharpe Ratio | NA | 0.27 | -0.27 | 0.03 | 0.4 | 0.4 | NA | NA | NA | NA | 0.56 | -0.06 | 0.78 | -0.63 | 0.99 | 1.01 | 3.05 | -0.53 | 1.49 | 0.24 | -0.24 | 0.07 | 2.93 | 2.05 | 0.36 | 1.53 | 1.63 | -1.35 | 0.92 | 1.3 | 0.89 | 1.51 | 3.19 | -0.48 | 0.84 |
Draw Down(%) | NA | 1.9 | 7.3 | 17.7 | 24.9 | 24.9 | NA | NA | NA | NA | 32.7 | 6.8 | 7.7 | 21.5 | 5.6 | 22.9 | 3.0 | 10.2 | 2.6 | 7.3 | 8.4 | 7.1 | 3.4 | 3.4 | 7.5 | 7.1 | 14.3 | 29.6 | 4.9 | 6.4 | 4.4 | 5.7 | 6.6 | 14.8 | 9.9 |
Standard Deviation(%) | NA | 7.2 | 8.7 | 12.5 | 14.3 | 11.5 | NA | NA | NA | NA | 9.9 | 8.9 | 8.1 | 18.3 | 11.7 | 20.5 | 7.1 | 9.3 | 5.3 | 7.1 | 8.5 | 7.2 | 5.3 | 4.6 | 8.1 | 8.0 | 13.3 | 16.7 | 6.8 | 6.0 | 5.4 | 6.8 | 6.6 | 8.6 | 7.8 |
Treynor Ratio | NA | 0.04 | -0.04 | 0.01 | 0.11 | 0.09 | NA | NA | NA | NA | 0.13 | -0.01 | 0.12 | -0.24 | 0.21 | 0.37 | 0.43 | -0.1 | 0.13 | 0.03 | -0.04 | 0.01 | 0.36 | 0.28 | 0.09 | 0.29 | 0.47 | -0.59 | 0.16 | 0.15 | 0.11 | 0.2 | 0.66 | -0.15 | 0.22 |
Alpha | NA | 0.04 | -0.03 | -0.01 | 0.0 | 0.0 | NA | NA | NA | NA | 0.01 | -0.04 | -0.02 | 0.0 | -0.01 | 0.04 | 0.03 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.04 | -0.03 | 0.02 | 0.01 | 0.02 | 0.02 | 0.05 | 0.01 | 0.04 |
Beta | NA | 0.5 | 0.58 | 0.52 | 0.54 | 0.54 | NA | NA | NA | NA | 0.44 | 0.61 | 0.55 | 0.48 | 0.56 | 0.57 | 0.5 | 0.51 | 0.61 | 0.5 | 0.52 | 0.6 | 0.43 | 0.33 | 0.33 | 0.42 | 0.46 | 0.38 | 0.39 | 0.52 | 0.45 | 0.52 | 0.32 | 0.28 | 0.3 |
RSquared | NA | 0.85 | 0.75 | 0.51 | 0.65 | 0.7 | NA | NA | NA | NA | 0.72 | 0.75 | 0.78 | 0.41 | 0.38 | 0.91 | 0.78 | 0.89 | 0.6 | 0.85 | 0.89 | 0.89 | 0.81 | 0.85 | 0.89 | 0.88 | 0.9 | 0.88 | 0.85 | 0.76 | 0.74 | 0.73 | 0.69 | 0.71 | 0.67 |
Sortino Ratio | NA | 0.4 | -0.35 | 0.04 | 0.55 | 0.55 | NA | NA | NA | NA | 0.76 | -0.08 | 1.15 | -0.86 | 1.47 | 1.33 | 4.5 | -0.68 | 1.97 | 0.34 | -0.32 | 0.09 | 4.52 | 3.25 | 0.48 | 2.18 | 2.35 | -1.74 | 1.23 | 1.91 | 1.33 | 2.09 | 5.0 | -0.68 | 1.18 |
Yield(%) | N/A | 0.0 | 2.7 | 3.6 | 6.0 | 5.1 | 6.3 | 6.3 | 6.7 | 6.7 | 3.68 | 2.9 | 3.7 | 4.1 | 10.7 | 2.4 | 1.7 | 2.3 | 1.4 | 4.2 | 5.4 | 3.0 | 3.8 | 2.9 | 2.6 | 2.9 | 2.0 | 2.3 | 4.9 | 3.7 | 2.9 | 3.7 | 3.5 | 4.0 | 6.0 |
Dividend Growth(%) | N/A | -98.2 | -10.8 | -17.3 | 148.3 | 134.9 | N/A | N/A | N/A | N/A | N/A | -16.5 | -18.4 | -56.9 | 446.4 | 67.2 | -26.8 | 83.3 | -66.4 | -25.7 | 81.2 | -10.1 | 43.9 | 16.7 | 0.1 | 76.7 | -30.2 | -49.3 | 45.2 | 38.9 | -13.5 | 25.9 | -12.9 | -28.8 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 12/31/2000
Portfolio Description
This model portfolio uses Strategic Asset Allocation - Equal Weight
. The allocations are diversified by investing in the 3 major asset classes: Fixed Income, US Equity, Foreign Equity
that are covered in Encore Dermatology 401(k) and Profit Sharing Plan. It then selects one or two funds for each of the 3 major asset classes.
1.Risk allocation: the risk profile of this portfolio 40.
The total allocation of the fixed income assets should be at least 40%.
2.Asset weights: risk assets selected are equally weighted by
default.
3.Fund selection: about one or two top performing funds among 23 available funds in the plan are chosen for each asset selected. They are usually equally weighted within
the asset by default.
4.Rebalance frequency: the portfolio is reviewed by the strategy program monthly
and the above steps are repeated. Asset weights are rebalanced back to target allocation if it is necessary.
5.
Simulation: Performance data before this portfolio went public on
10/27/2017
are obtained from historical simulation. They are hypothetical.